Delivery Order SPE2DB25D3306-SPE2DB25FUBSN
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Qulipta 60 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $5,911.90 and a performance period ending on April 17, 2025. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's costs. This contract is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,738.34 firm-fixed-price contract is for the delivery of Qulipta 60 mg tablets, a medication used to treat migraines. The contract has a period of performance through November 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Qulipta 60 mg tablets, a medication used in the treatment of migraines. The award has a ceiling value of $1,498.41 and a period of performance through April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp...
This federal contract award, with an ID of SPE2DB24D2003|SPE2DB25FXHN0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Qulipta 60 mg tablets, a medication used in the treatment of migraines. The contract has a firm fixed price of $1,154.79 and an ultimate completion date of May 29, 2025. This contract is not a set-aside and is therefore open to...
This federal contract award, valued at $2,694.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Qulipta 60 mg tablets, a medication used to treat migraines. This is a firm-fixed-price delivery order with a completion date of May 22, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.14, is for the supply of Qulipta 30 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order, with a performance period through February 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Qulipta 30 mg tablets. The contract has a firm fixed price of $4,752.14 and an ultimate completion date of August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,694.51, is for the delivery of 4,568,104,420 units of the medication Qulipta 60 mg tablet. The contract has a firm fixed price and is not a set-aside procurement. It has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug Qulipta (60 mg tablet, 30s) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $4,750.07 and a performance period through May 14, 2025. This award is not set aside and represents an open competition contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.72 delivery order contract is for the supply of the medication Qulipta 60 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 21, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...